SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cell Genesys (CEGE)
An SI Board Since April 1996
Posts SubjectMarks Bans Symbol
1298 85 0 CEGE
Emcee:  Bharat Kalra Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1248<<CEGE is still undervalued, BIOM is not>> So far the market seems Area51-6/17/2003
1247What a horrific call on BIOM.... Any way, do you think BIOM is worth buying NOWValery Portnov-6/17/2003
1246Your reasons are valid for almost any biotech stock, besides, BIOM is tanking onValery Portnov-6/16/2003
1245I think the CEGE science is enthralling (at one time this company was my largestArea51-6/14/2003
1244Cell Genesys: GVAX Treatment Safe, Well Tolerated Monday June 2, 12:24 pm ET SemiBull-6/2/2003
1243>> Mr. Market seems unimprssed by these results. Both are interim; not surIcebrg-6/2/2003
1242Mr. Market seems unimpressed by these results. Both are interim; not sure what tuck-6/2/2003
1241Cell Genesys Reports First Quarter Financial Results Monday April 28, 4:02 pm ESemiBull-4/28/2003
1240Cell Genesys President Elected to California Healthcare Institute Board TuesdaySemiBull-4/22/2003
1239Cell Genesys Launches Phase 1/2 Trial of CG7870 Plus Radiation Therapy in Early-SemiBull-4/22/2003
1238Cell Genesys to Present Data From GVAX(R) Prostate Cancer and Myeloma Vaccine ClSemiBull-4/2/2003
1237>>SOUTH SAN FRANCISCO, Calif., April 1 /PRNewswire-FirstCall/ -- Cell Genetuck-4/1/2003
1236Ceregene Licenses Genes From Genentech for Neurological Gene Therapies WednesdaSemiBull-3/26/2003
1235I'm glad they didn't report discouraging results. The thing has done notArea51-3/18/2003
1234Cell Genesys Reports Encouraging Update From Initial Clinical Trial of GVAX(R) LSemiBull-2/13/2003
1233Cell Genesys Increases Cancer Product Focus and Eliminates Broad-Based Gene TherSemiBull-2/4/2003
1232CEGE down to about $5/share in cash, but I would expect the burn to slow down betuck-1/29/2003
1231Cell Genesys Receives $15 Million from TKT for Remainder of License Fee In Gene nigel bates-1/22/2003
1230CEGE did dump about 250k ABGX when it was trading at roughly $9.70. Smart move.Londo-1/9/2003
1229I take it you mean the shelf. I was surprised to see that, as they appear to hatuck-1/8/2003
1228I think the secondary offering is hanging like an albatross over this stock.chuckj-1/8/2003
1227Antigenics to test cancer drug in leukemia patients Monday December 16, 4:22 pmSemiBull-12/17/2002
1226>>SAN DIEGO, Calif., Dec. 16 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. tuck-12/16/2002
1225>>SAN DIEGO, Dec. 13 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. (Nasdaq:tuck-12/13/2002
1224>>FOSTER CITY, Calif., Dec. 11 /PRNewswire-FirstCall/ -- Cell Genesys, Inctuck-12/11/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News